Pricing
Login
Home
Charts
Search
Watchlist
Products

SMS Pharmaceuticals Ltd

SMSPHARMA
₹473.25-1.68%20 Nov 2026
Reports
Pharma API

SMS Pharmaceuticals Ltd

SMSPHARMA
₹473.25
-1.68%
20 Nov 2026
Ask AI
6M
Price
Charts
Documents

Quick Ratios

Edit Ratios
Mkt Cap
Market Capitalization
₹4,432Cr
Close
Close Price
₹473.25
Industry
Industry
Pharma API
PE
Price To Earnings
37.38
PS
Price To Sales
4.56
Revenue
Revenue
₹971Cr
Rev Gr TTM
Revenue Growth TTM
12.96%
PAT Gr TTM
PAT Growth TTM
28.30%

Quarterly Results

Consolidated
Standalone
Numbers
Percentage
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
161246164197173248196242210238207316
Growth YoY
Revenue Growth YoY%
8.564.521.518.17.31.019.223.221.4-4.15.630.4
Expenses
ExpensesCr
132212131165140207157194167198166248
Operating Profit
Operating ProfitCr
293434313341394844404168
OPM
OPM%
18.013.720.416.019.216.420.119.920.716.819.821.4
Other Income
Other IncomeCr
121121114321
Interest Expense
Interest ExpenseCr
665545666566
Depreciation
DepreciationCr
888999101010101010
PBT
PBTCr
172222202229243431272753
Tax
TaxCr
4656586986713
PAT
PATCr
121616141720192523212040
Growth YoY
PAT Growth YoY%
132.898.985.815.039.025.114.381.335.84.48.057.5
NPM
NPM%
7.66.59.97.09.88.19.510.411.08.89.812.5
EPS
EPS₹
1.42.01.91.72.12.42.32.82.63.62.24.3
QuarterDec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Revenue
RevenueCr
161246164197173248196242210238207316
Growth YoY
Revenue Growth YoY%
8.564.521.518.17.31.019.223.221.4-4.15.630.4
Expenses
ExpensesCr
132212131165140207157194167198166248
Operating Profit
Operating ProfitCr
293434313341394844404168
OPM
OPM%
18.013.720.416.019.216.420.119.920.716.819.821.4
Other Income
Other IncomeCr
121121114321
Interest Expense
Interest ExpenseCr
665545666566
Depreciation
DepreciationCr
888999101010101010
PBT
PBTCr
172222202229243431272753
Tax
TaxCr
4656586986713
PAT
PATCr
121616141720192523212040
Growth YoY
PAT Growth YoY%
132.898.985.815.039.025.114.381.335.84.48.057.5
NPM
NPM%
7.66.59.97.09.88.19.510.411.08.89.812.5
EPS
EPS₹
1.42.01.91.72.12.42.32.82.63.62.24.3

Profit & Loss

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
603438463465412563520522709783887971
Growth
Revenue Growth%
-27.45.60.5-11.436.7-7.70.435.910.413.313.0
Expenses
ExpensesCr
514363369375332442406468593644716779
Operating Profit
Operating ProfitCr
897593908012111454117139171192
OPM
OPM%
14.817.120.219.419.421.522.010.416.417.819.319.8
Other Income
Other IncomeCr
412353554689
Interest Expense
Interest ExpenseCr
171515121211192223192323
Depreciation
DepreciationCr
191920192222323232344041
PBT
PBTCr
5642606251916956692117138
Tax
TaxCr
156202118301117252934
PAT
PATCr
423640413361684496788104
Growth
PAT Growth%
-14.513.62.5-21.186.511.3-94.31,166.737.030.628.3
NPM
NPM%
6.98.18.78.97.910.813.10.76.98.69.910.7
EPS
EPS₹
4.83.43.84.73.77.47.3-0.85.98.211.212.7
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Revenue
RevenueCr
603438463465412563520522709783887971
Growth
Revenue Growth%
-27.45.60.5-11.436.7-7.70.435.910.413.313.0
Expenses
ExpensesCr
514363369375332442406468593644716779
Operating Profit
Operating ProfitCr
897593908012111454117139171192
OPM
OPM%
14.817.120.219.419.421.522.010.416.417.819.319.8
Other Income
Other IncomeCr
412353554689
Interest Expense
Interest ExpenseCr
171515121211192223192323
Depreciation
DepreciationCr
191920192222323232344041
PBT
PBTCr
5642606251916956692117138
Tax
TaxCr
156202118301117252934
PAT
PATCr
423640413361684496788104
Growth
PAT Growth%
-14.513.62.5-21.186.511.3-94.31,166.737.030.628.3
NPM
NPM%
6.98.18.78.97.910.813.10.76.98.69.910.7
EPS
EPS₹
4.83.43.84.73.77.47.3-0.85.98.211.212.7
Sales CAGR
1 Year13%
3 Years19%
5 Years10%
TTM13%
EBITDA CAGR
1 Year23%
3 Years47%
5 Years7%
TTM19%
PAT CAGR
1 Year31%
3 Years183%
5 Years8%
TTM28%
Avg. ROCE
1 Year12%
3 Years12%
5 Years10%
TTM14%
CFO / EBITDA
1 Year35%
3 Years45%
5 Years43%
TTM-

Balance Sheet

Consolidated
Standalone
Numbers
Percentage
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
888888888999
Reserves
ReservesCr
285246276313340402462452499615776833
Current Liabilities
Current LiabilitiesCr
200147121143145195196255332324353411
Non Current Liabilities
Non Current LiabilitiesCr
162919794114206193164166189224207
Total Liabilities
Total LiabilitiesCr
6564935035596088128608801,0341,1531,3621,461
Current Assets
Current AssetsCr
248157168208219309377411534554638686
Non Current Assets
Non Current AssetsCr
408336334351389503482469500598724775
Total Assets
Total AssetsCr
6564935035596088128608801,0341,1531,3621,461
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital
Equity CapitalCr
888888888999
Reserves
ReservesCr
285246276313340402462452499615776833
Current Liabilities
Current LiabilitiesCr
200147121143145195196255332324353411
Non Current Liabilities
Non Current LiabilitiesCr
162919794114206193164166189224207
Total Liabilities
Total LiabilitiesCr
6564935035596088128608801,0341,1531,3621,461
Current Assets
Current AssetsCr
248157168208219309377411534554638686
Non Current Assets
Non Current AssetsCr
408336334351389503482469500598724775
Total Assets
Total AssetsCr
6564935035596088128608801,0341,1531,3621,461

Cash Flow

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
6173325040904522508259
Investing Cash Flow
Investing Cash FlowCr
-97-39-17-35-43-152-27-30-52-123-131
Financing Cash Flow
Financing Cash FlowCr
27-33-15-13-292-12-32314776
Net Cash Flow
Net Cash FlowCr
-9102-5316-392954
Free Cash Flow
Free Cash FlowCr
-27502315-3-6118-7-2-42-71
CFO To PAT
CFO To PAT%
147.0206.378.6120.0121.5148.466.4578.0101.9121.267.3
CFO To EBITDA
CFO To EBITDA%
68.698.234.155.249.774.739.441.243.058.834.6
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Operating Cash Flow
Operating Cash FlowCr
6173325040904522508259
Investing Cash Flow
Investing Cash FlowCr
-97-39-17-35-43-152-27-30-52-123-131
Financing Cash Flow
Financing Cash FlowCr
27-33-15-13-292-12-32314776
Net Cash Flow
Net Cash FlowCr
-9102-5316-392954
Free Cash Flow
Free Cash FlowCr
-27502315-3-6118-7-2-42-71
CFO To PAT
CFO To PAT%
147.0206.378.6120.0121.5148.466.4578.0101.9121.267.3
CFO To EBITDA
CFO To EBITDA%
68.698.234.155.249.774.739.441.243.058.834.6

Ratios

Consolidated
Standalone
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
7067256235272261,0537944891,5071,8863,5094,432
Price To Earnings
Price To Earnings
17.425.419.613.27.116.812.830.227.334.437.4
Price To Sales
Price To Sales
1.11.71.41.10.61.91.50.92.12.44.04.6
Price To Book
Price To Book
2.42.92.21.60.72.61.71.13.03.04.55.3
EV To EBITDA
EV To EBITDA
9.811.37.97.24.410.58.813.515.015.522.424.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
24.526.029.929.532.032.636.425.429.833.834.134.1
OPM
OPM%
14.817.120.219.419.421.522.010.416.417.819.319.8
NPM
NPM%
6.98.18.78.97.910.813.10.76.98.69.910.7
ROCE
ROCE%
15.314.718.316.313.115.411.93.811.411.912.113.5
ROE
ROE%
14.214.014.212.99.414.814.40.89.710.811.212.3
ROA
ROA%
6.37.28.17.45.47.57.90.44.85.86.57.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Financial YearMar 2016Mar 2017Mar 2018Mar 2019Mar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Current
Valuation Ratios
Valuation Ratios
Market Cap
Market CapitalizationCr
7067256235272261,0537944891,5071,8863,5094,432
Price To Earnings
Price To Earnings
17.425.419.613.27.116.812.830.227.334.437.4
Price To Sales
Price To Sales
1.11.71.41.10.61.91.50.92.12.44.04.6
Price To Book
Price To Book
2.42.92.21.60.72.61.71.13.03.04.55.3
EV To EBITDA
EV To EBITDA
9.811.37.97.24.410.58.813.515.015.522.424.7
Profitability Ratios
Profitability Ratios
GPM
GPM%
24.526.029.929.532.032.636.425.429.833.834.134.1
OPM
OPM%
14.817.120.219.419.421.522.010.416.417.819.319.8
NPM
NPM%
6.98.18.78.97.910.813.10.76.98.69.910.7
ROCE
ROCE%
15.314.718.316.313.115.411.93.811.411.912.113.5
ROE
ROE%
14.214.014.212.99.414.814.40.89.710.811.212.3
ROA
ROA%
6.37.28.17.45.47.57.90.44.85.86.57.1
Operational Ratios
Operational Ratios
Solvency Ratios
Solvency Ratios
Liquidity Ratios
Liquidity Ratios
Market CapitalizationMkt CapCr4,9914,9404,5904,4324,4223,0501,338
Close PriceClose₹620.1590.15352.70473.25484.50628.2525.17
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE28.1826.28213.7637.3819.3482.0230.70
Price To SalesPS5.682.1627.684.561.551.994.78
RevenueRevenueCr8792,2861669712,8511,535280
Revenue Growth TTMRev Gr TTM%23.0%30.2%13.0%15.1%27.3%
PAT Growth TTMPAT Gr TTM%-2.8%89.5%28.3%14.9%476.3%
Market CapitalizationMkt CapCr4,9914,9404,5904,4324,4223,0501,338
Close PriceClose₹620.1590.15352.70473.25484.50628.2525.17
IndustryIndustryPharma APIPharma APIPharma APIPharma APIPharma APIPharma APIPharma API
Price To EarningsPE28.1826.28213.7637.3819.3482.0230.70
Price To SalesPS5.682.1627.684.561.551.994.78
RevenueRevenueCr8792,2861669712,8511,535280
Revenue Growth TTMRev Gr TTM%23.0%30.2%13.0%15.1%27.3%
PAT Growth TTMPAT Gr TTM%-2.8%89.5%28.3%14.9%476.3%
Annual Reports
FY2026
FY2025
FY2024
FY2023
FY2022
FY2021
FY2020
Quarterly Reports
FY2026
Jun 26
ResultPPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
ResultPPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Dec 24
ResultPPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Dec 21
ResultPPT
Transcript
Summary
Sep 21
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Annual Reports
Quarterly Reports
Jun 26
ResultPPT
Transcript
Summary
Dec 25
ResultPPT
Transcript
Summary
Sep 25
ResultPPT
Transcript
Summary
Jun 25
ResultPPT
Transcript
Summary
Dec 24
ResultPPT
Transcript
Summary
Sep 24
ResultPPT
Transcript
Summary
Dec 21
ResultPPT
Transcript
Summary
Sep 21
Jun 21
Result
PPT
Transcript
Summary
Mar 21
Result
PPT
Transcript
Summary
Dec 20
Result
PPT
Transcript
Summary
Jun 20
Result
PPT
Transcript
Summary
Load More
Interviews